The effect of hospitalization on oral anticoagulation control: a population-based study
- PMID: 16844204
- DOI: 10.1016/j.thromres.2006.05.017
The effect of hospitalization on oral anticoagulation control: a population-based study
Abstract
Background: For patients taking oral anticoagulants (OAC), the proportion of time spent in the therapeutic range is strongly associated with bleeding and thromboembolic risk. Previous studies examining OAC control may not generalize because the patient population was select or INR capture was incomplete.
Objectives: Measure OAC control for an entire population of elderly people and determine patient factors associated with OAC control.
Patients: People in Eastern Ontario without valve replacement aged 65 years or greater who were treated with warfarin between 1 September 1999 and 1 September 2000.
Design: Retrospective cohort study using population-based administrative databases. OAC control was measured as the proportion of days in therapeutic range (PDTR), defined as the number days with the INR between 2 and 3 divided by total number of days observation. Linear interpolation was used to determine INR levels between measures. Negative binomial regression was used to identify patient factors independently associated with PDTR. We also determined which factors were associated with proportion of days with a critically low (<1.5) or critically high (>/=5) INR.
Results: 7179 people were followed for a total of 3238 years. 15% of people were hospitalized during the study. Overall, PDTR was 59.2% (95% CI 59.1%-59.2%). Independent of all other significant factors, hospitalization was associated with a 15% decrease in the PDTR 15% (rate ratio 0.85, 95% CI 0.83-0.87). Hospitalization was also independently associated with greater proportion of time with a critically low INR (rate ratio 1.68, 95% CI 1.51-1.88) and a critically high INR (1.70, 95% CI 1.38-2.08).
Conclusions: Elderly people in eastern Ontario taking warfarin were therapeutic 59.2% of the time. Independent of other patient factors, patients who are hospitalized have the greatest risk of poor anticoagulation control. Control for anticoagulated patients who get hospitalized should be reviewed to determine if and how it could be improved.
Similar articles
-
Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.Pharmacotherapy. 2008 Aug;28(8):960-7. doi: 10.1592/phco.28.8.960. Pharmacotherapy. 2008. PMID: 18657012
-
Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population.Curr Med Res Opin. 2005 Dec;21(12):1905-13. doi: 10.1185/030079905X75050. Curr Med Res Opin. 2005. PMID: 16368039
-
Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population.Ann Pharmacother. 2009 Jul;43(7):1165-72. doi: 10.1345/aph.1L707. Epub 2009 Jun 23. Ann Pharmacother. 2009. PMID: 19549747
-
Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.Pharmacotherapy. 2008 Apr;28(4):540-8. doi: 10.1592/phco.28.4.540. Pharmacotherapy. 2008. PMID: 18363538 Review.
-
Self-management of anticoagulation.Expert Rev Cardiovasc Ther. 2008 Aug;6(7):979-85. doi: 10.1586/14779072.6.7.979. Expert Rev Cardiovasc Ther. 2008. PMID: 18666848 Review.
Cited by
-
Impact of a pharmacotherapeutic programme on control and safety of long-term anticoagulation treatment: a controlled follow-up study in Spain.Drug Saf. 2011 Jun 1;34(6):489-500. doi: 10.2165/11588520-000000000-00000. Drug Saf. 2011. PMID: 21585221 Clinical Trial.
-
Frequency of adverse events in patients with poor anticoagulation: a meta-analysis.CMAJ. 2007 May 22;176(11):1589-94. doi: 10.1503/cmaj.061523. CMAJ. 2007. PMID: 17515585 Free PMC article. Review.
-
Inpatient warfarin management: pharmacist management using a detailed dosing protocol.J Thromb Thrombolysis. 2012 Feb;33(2):178-84. doi: 10.1007/s11239-011-0655-9. J Thromb Thrombolysis. 2012. PMID: 22081292 Clinical Trial.
-
Patterns and outcomes of prescribing venous thromboembolism prophylaxis in hospitalized older adults: a retrospective cohort study.J Thromb Thrombolysis. 2018 Apr;45(3):369-376. doi: 10.1007/s11239-018-1611-8. J Thromb Thrombolysis. 2018. PMID: 29330739
-
Comorbidities against quality control of VKA therapy in non-valvular atrial fibrillation: a French national cross-sectional study.PLoS One. 2015 Mar 19;10(3):e0119043. doi: 10.1371/journal.pone.0119043. eCollection 2015. PLoS One. 2015. PMID: 25789771 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical